Glucocorticoids: Clinical Trials

23 trials of Glucocorticoids, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 4 unknown, 3 terminated, 2 not yet recruiting. 23 Phase 3, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 323Completed 11, Unknown 4, Terminated 3, Not yet recruiting 2, Recruiting 2, Active not recruiting 1
Phase 28Completed 6, Not yet recruiting 1, Unknown 1

Follow Glucocorticoids: new trials by email Literature Review of Glucocorticoids trials Research Report on Glucocorticoids

Trials (filtered) newest first · largest first

All 23 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Autologous Circulating Extracellular Vesicles for Total-Type Sudden Sensorineural Hearing Loss
autologous circulating extracellular vesicles, Glucocorticoids - Sudden Sensorineural Hearing Loss (SSNHL)
Phase 3Not yet recruitingSun Yat-Sen Memorial Hospital of Sun Yat-Sen University1462026-09-152026-10-16
A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome
Momelotinib, Glucocorticoids, Placebo - VEXAS Syndrome
Phase 2 / Phase 3Not yet recruitingGlaxoSmithKline1362026-08-052026-06-01
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Rilzabrutinib, Placebo, Glucocorticoid - Immunoglobulin G4 Related Disease
Phase 3RecruitingSanofi1242025-09-262026-10-20
OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study)
Obinutuzumab, CTX combined with Glucocorticoids - Primary Membranous Nephropathy
Phase 3RecruitingHuashan Hospital1442024-10-232026-01-21
A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4
SRP-9003, Glucocorticoid - Limb-girdle Muscular Dystrophy
Phase 3Active not recruitingSarepta Therapeutics, Inc.172024-01-152026-03-02
Effectiveness of Probiotics in Patients of Mild to Moderate Rheumatoid Arthritis
probiotic plus standard treatment, standard treatment - Rheumatoid Arthritis
Phase 3CompletedKing Edward Medical University882023-08-242024-09-19
Sinomenine Versus Glucocorticoid for Knee OA
Sinomenine, Glucocorticoid - Knee Osteoarthritis
Phase 3UnknownShanghai 6th People's Hospital3282023-02-282023-03-10
A Study With Imlifidase in Anti-GBM Disease
Imlifidase, Plasma exchange (PLEX), Cyclophosphamide (CYC) - Anti-Glomerular Basement Membrane Disease, Anti-Glomerular Basement Membrane Antibody Disease
Phase 3TerminatedHansa Biopharma AB502022-12-222026-03-04
Study of Therapeutic Value of Periorbital Injection of Glucocorticoid in Mild TAO
Glucocorticoids - Thyroid Associated Ophthalmopathy
Phase 3UnknownSun Yat-sen University1422021-05-012021-05-18
A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)
Tocilizumab Prefilled Syringe [Actemra], Placebos, Glucocorticoids - Polymyalgia Rheumatica
Phase 3CompletedMedical University of Vienna392017-11-242021-01-22
Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis
MMF, CYC, Glucocorticoids - Takayasu Arteritis
Phase 3CompletedChinese SLE Treatment And Research Group1382017-03-162023-08-30
A Study Evaluating Vitamin D in Allergic Bronchopulmonary Aspergillosis Complicating Asthma
Glucocorticoids, Vitamin D - Allergic Bronchopulmonary Aspergilloses
Phase 2 / Phase 3CompletedPost Graduate Institute of Medical Education and Research, Chandigarh302016-12-012018-08-23
Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy
Methotrexate, Leflunomide, Hydroxychloroquine - Rheumatoid Arthritis
Phase 3TerminatedJawaharlal Institute of Postgraduate Medical Education & Research1362016-09-012021-07-27
A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis
Itraconazole, Glucocorticoids - Allergic Bronchopulmonary Aspergillosis
Phase 2 / Phase 3CompletedPost Graduate Institute of Medical Education and Research, Chandigarh1912014-05-012022-10-07
The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach
5 mg prednisone, 0 mg prednisone - Granulomatosis With Polyangiitis, Wegener Granulomatosis
Phase 3UnknownUniversity of South Florida122014-02-172024-07-29
The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach
5 mg Prednisone, 0 mg Prednisone - Granulomatosis With Polyangiitis
Phase 3CompletedUniversity of Pennsylvania1592014-02-012026-08-06
Diagnostic Value of Oral Prednisolone Test for Rheumatoid Arthritis
Prednisolone - Rheumatoid Arthritis
Phase 2 / Phase 3CompletedRheumazentrum Ruhrgebiet1302012-02-012015-05-18
Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Disease
Biological: mesenchymal stem cell, Cyclosporine and Glucocorticoid - Chronic Graft Versus Host Disease
Phase 2 / Phase 3UnknownChinese Academy of Medical Sciences1002012-02-012012-08-03
Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's Granulomatosis
Gusperimus + glucocorticoids, cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids - Wegeners Granulomatosis
Phase 3TerminatedNordic Pharma SAS42011-11-012015-05-29
Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary Aspergillosis
Glucocorticoids, Itraconazole - Allergic Bronchopulmonary Aspergillosis
Phase 2 / Phase 3CompletedPost Graduate Institute of Medical Education and Research, Chandigarh1002011-04-012017-03-16

Showing 20 of 23. Sign in to see all of them.

Conditions studied

Aspergillosis, Allergic Bronchopulmonary (4)  ·  Granulomatosis with Polyangiitis (4)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (3)  ·  Arthritis, Rheumatoid (3)  ·  Vasculitis (3)  ·  Anti-Glomerular Basement Membrane Disease (1)  ·  Asthma (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Cardiovascular Diseases (1)  ·  Disease (1)  ·  Graves Ophthalmopathy (1)  ·  Hearing Loss, Sudden (1)  ·  Heart Failure (1)  ·  Hypersensitivity (1)  ·  Immunoglobulin G4-Related Disease (1)

Sponsors

Post Graduate Institute of Medical Education and Research, Chandigarh (4)  ·  University of Pennsylvania (2)  ·  Chinese Academy of Medical Sciences (1)  ·  Chinese SLE Treatment And Research Group (1)  ·  GlaxoSmithKline (1)  ·  Hansa Biopharma AB (1)  ·  Hebei Medical University (1)  ·  Huashan Hospital (1)  ·  Jawaharlal Institute of Postgraduate Medical Education & Research (1)  ·  King Edward Medical University (1)  ·  Medical University of Vienna (1)  ·  Nordic Pharma SAS (1)  ·  Rheumazentrum Ruhrgebiet (1)  ·  Sanofi (1)  ·  Sarepta Therapeutics, Inc. (1)

Countries

China (7)  ·  United States (6)  ·  India (5)  ·  Belgium (4)  ·  Germany (4)  ·  Italy (4)  ·  United Kingdom (4)  ·  Canada (3)  ·  Czechia (3)  ·  France (3)  ·  Spain (3)  ·  Sweden (3)  ·  Austria (2)  ·  Denmark (2)  ·  Japan (2)

Top investigators

David Jayne, MD (2)  ·  Peter A Merkel, MD, MPH (2)  ·  Ritesh Agarwal, MD, DM (2)  ·  Chunhua Zhao, MD,PHD (1)  ·  Gulraiz Iqbal, MBBS (1)  ·  Haidi Yang, Doctor (1)  ·  He Huang, MD (1)  ·  Huasheng Yang, Doctor (1)  ·  Jeffery P Krischer, PhD (1)  ·  Jeffrey P Krischer, PhD (1)  ·  Juergen Braun, MD (1)  ·  Kunshen Liu, MD (1)

Results publications

PMID 39425055, PMID 10068416, PMID 16221103, PMID 17332971, PMID 20054700, PMID 26585431, PMID 27924855, PMID 28246067, PMID 28388956, PMID 29331473, PMID 30561849, PMID 32053298, PMID 34586472, PMID 35210264, PMID 36155131, PMID 38346237, PMID 41560786

NIH funding

2025 (2), R01HL115041 (2), 2009 (1), 2016 (1), U54AR057319 (1)